ARTICLE SUMMARY:
Research and development is the lifeline of all medical device companies, large and small. While some rely more heavily on the “R” and others on the “D,” together those functions fuel the industry’s product innovation pipeline. Here Medtronic’s former CEO, Art Collins, outlines what he sees as the critical elements of a successful R&D program, borne out of his 30 years of industry experience. By Art Collins, Medtronic.
When my friend Pete McNerney asked me to be the speaker at a recent Kellogg Graduate School of Management event in Chicago, I gladly accepted.
